FUSN - Fusion Pharmaceuticals Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Hamilton,
Canada
Type: Equity
FUSN price evolution
FUSN
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $62.77 | $28.11 | $33.29 | $54.88 |
| Short term investments | $172.15 | $164.56 | $166.07 | $156.23 |
| Net receivables | $0.01 | $0.04 | $0.06 | $0.09 |
| Inventory | ||||
| Total current assets | $243.4 | $203.26 | $207.86 | $220.62 |
| Long term investments | $13.73 | $15.93 | $28.42 | $11.34 |
| Property, plant & equipment | $23.9 | $24.98 | $23.34 | $22.98 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $42.44 | $50.11 | $60.43 | $45.93 |
| Total investments | $185.89 | $180.49 | $194.5 | $167.56 |
| Total assets | $285.84 | $253.38 | $268.29 | $266.55 |
| Current liabilities | ||||
| Accounts payable | $1.86 | $1.06 | $2.06 | $1.9 |
| Deferred revenue | $1 | $1 | $3 | $3 |
| Short long term debt | $4.16 | $6.17 | $5.36 | $4.64 |
| Total current liabilities | $16.22 | $17.48 | $17.09 | $17.32 |
| Long term debt | $46.17 | $46.46 | $45.27 | $45.43 |
| Total noncurrent liabilities | $47.14 | $47.43 | $48.23 | $48.39 |
| Total debt | $50.33 | $52.63 | $50.62 | $50.06 |
| Total liabilities | $63.36 | $64.91 | $65.33 | $65.72 |
| Shareholders' equity | ||||
| Retained earnings | -$376.76 | -$348.58 | -$331.33 | -$306.15 |
| Other shareholder equity | $0.24 | -$0.84 | -$0.25 | -$0.09 |
| Total shareholder equity | $222.48 | $188.47 | $202.96 | $200.83 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $62.77 | $43.86 | $54.79 | $92.41 |
| Short term investments | $172.15 | $127.01 | $147.9 | $131.88 |
| Net receivables | $0.01 | $1.72 | $0.36 | $0.8 |
| Inventory | ||||
| Total current assets | $243.4 | $179 | $211.76 | $228.16 |
| Long term investments | $13.73 | $15.76 | $19.99 | $77.08 |
| Property, plant & equipment | $23.9 | $10.31 | $9.45 | $1.97 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $42.44 | $40.07 | $40.51 | $82.51 |
| Total investments | $185.89 | $142.77 | $167.88 | $208.96 |
| Total assets | $285.84 | $219.06 | $252.27 | $310.68 |
| Current liabilities | ||||
| Accounts payable | $1.86 | $2.69 | $2.19 | $3.4 |
| Deferred revenue | $1 | $3 | $4.04 | $5 |
| Short long term debt | $4.16 | $1.44 | $1.22 | |
| Total current liabilities | $16.22 | $15.07 | $12.51 | $11.86 |
| Long term debt | $46.17 | $34.23 | $5.51 | |
| Total noncurrent liabilities | $47.14 | $41.78 | $8.3 | $4.31 |
| Total debt | $50.33 | $40.25 | $6.72 | |
| Total liabilities | $63.36 | $56.84 | $20.82 | $16.16 |
| Shareholders' equity | ||||
| Retained earnings | -$376.76 | -$281.86 | -$194.25 | -$113.2 |
| Other shareholder equity | $0.24 | -$0.47 | -$0.12 | $0.04 |
| Total shareholder equity | $222.48 | $162.22 | $231.46 | $294.51 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.01 | $0.03 | $0.03 | |
| Cost of revenue | ||||
| Gross Profit | $2.01 | $0.03 | $0.03 | |
| Operating activities | ||||
| Research & development | $20.65 | $14.59 | $18.99 | $15.88 |
| Selling, general & administrative | $7.63 | $6.81 | $7.75 | $9.01 |
| Total operating expenses | $28.27 | $21.39 | $26.75 | $24.88 |
| Operating income | -$28.27 | -$19.39 | -$26.71 | -$24.86 |
| Income from continuing operations | ||||
| EBIT | -$25.55 | -$16.18 | -$24.14 | -$23.08 |
| Income tax expense | $1.3 | -$0.25 | -$0.24 | -$0.01 |
| Interest expense | $1.34 | $1.32 | $1.28 | $1.22 |
| Net income | ||||
| Net income | -$28.18 | -$17.25 | -$25.18 | -$24.29 |
| Income (for common shares) | -$28.18 | -$17.25 | -$25.18 | -$24.29 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.07 | $1.46 | $1.44 | |
| Cost of revenue | ||||
| Gross Profit | $2.07 | $1.46 | $1.44 | |
| Operating activities | ||||
| Research & development | $70.1 | $58.9 | $56.36 | $17.19 |
| Selling, general & administrative | $31.2 | $30.6 | $27.1 | $20.74 |
| Total operating expenses | $101.3 | $89.5 | $83.45 | $37.94 |
| Operating income | -$99.23 | -$88.03 | -$82.02 | -$37.94 |
| Income from continuing operations | ||||
| EBIT | -$88.94 | -$87.65 | -$81.17 | -$75.39 |
| Income tax expense | $0.79 | -$1.84 | -$0.12 | $2.61 |
| Interest expense | $5.17 | $1.8 | $0.33 | |
| Net income | ||||
| Net income | -$94.9 | -$87.61 | -$81.05 | -$78.33 |
| Income (for common shares) | -$94.9 | -$87.61 | -$81.05 | -$79.72 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$28.18 | -$17.25 | -$25.18 | -$24.29 |
| Operating activities | ||||
| Depreciation | $1.21 | $1.04 | $0.93 | $0.68 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.25 | $2.99 | $3.05 | $3.15 |
| Total cash flows from operations | -$17.94 | -$18.84 | -$19.58 | -$25.43 |
| Investing activities | ||||
| Capital expenditures | -$1.48 | -$0.47 | -$0.71 | -$1.22 |
| Investments | -$3.76 | $13.8 | -$25.61 | -$23.3 |
| Total cash flows from investing | -$5.24 | $13.33 | -$26.32 | -$24.53 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $57.85 | $0.36 | $24.45 | $63.37 |
| Net borrowings | ||||
| Total cash flows from financing | $57.85 | $0.33 | $24.31 | $59.52 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $34.67 | -$5.18 | -$21.59 | $9.55 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$94.9 | -$87.61 | -$81.05 | -$78.33 |
| Operating activities | ||||
| Depreciation | $3.86 | $2.05 | $1.71 | $0.48 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $12.44 | $10.84 | $8.6 | $3.37 |
| Total cash flows from operations | -$81.8 | -$73.28 | -$75.74 | -$29.77 |
| Investing activities | ||||
| Capital expenditures | -$3.89 | -$2.14 | -$1.49 | -$1.12 |
| Investments | -$38.87 | $25.23 | $39.27 | -$209.33 |
| Total cash flows from investing | -$42.76 | $23.09 | $37.77 | -$210.45 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $146.04 | $6.04 | $0.62 | $197.68 |
| Net borrowings | $34.69 | |||
| Total cash flows from financing | $142.01 | $40.73 | $0.35 | $265.51 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $17.44 | -$9.46 | -$37.62 | $25.29 |
News
Fundamentals
| Market cap | $1.69B |
|---|---|
| Enterprise value | $1.68B |
| Shares outstanding | 79.70M |
| Revenue | $2.07M |
|---|---|
| EBITDA | -$85.08M |
| EBIT | -$88.94M |
| Net Income | -$94.90M |
| Revenue Q/Q | -100.00% |
| Revenue Y/Y | 41.55% |
| P/E ratio | -17.84 |
|---|---|
| EV/Sales | 812.57 |
| EV/EBITDA | -19.75 |
| EV/EBIT | -18.89 |
| P/S ratio | 818.58 |
| P/B ratio | 7.62 |
| Book/Share | 2.79 |
| Cash/Share | 0.79 |
| EPS | -$1.19 |
|---|---|
| ROA | -35.34% |
| ROE | -46.59% |
| Debt/Equity | 0.28 |
|---|---|
| Net debt/EBITDA | -0.01 |
| Current ratio | 15.01 |
| Quick ratio | 15.01 |